Healthcare M&A Outlook Bright in 2018


March 14, 2018
BioSpectrum Asia Healthcare M and A Outlook Bright in 2018

IQVIA Consulting Principal Shriharsha Sarkar joins other experts in examining Asia's healthcare M&A outlook.

"While mega-mergers or acquisitions are becoming less common, big pharma is increasingly looking to snap up start-up biotech firms to inject growth in their pipelines," Shriharsha says.